Compare · COR vs NUS
COR vs NUS
Side-by-side comparison of Cencora Inc. (COR) and Nu Skin Enterprises Inc. (NUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and NUS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $59.91B, about 235.5x NUS ($254.4M).
- Over the past year, COR is up 5.2% and NUS is down 37.2% - COR leads by 42.4 points.
- COR has hit the wire 7 times in the past 4 weeks while NUS has been quiet.
- COR has more recent analyst coverage (25 ratings vs 4 for NUS).
- Company
- Cencora Inc.
- Nu Skin Enterprises Inc.
- Price
- $307.84-0.03%
- $5.23-3.33%
- Market cap
- $59.91B
- $254.4M
- 1M return
- +9.52%
- +3.98%
- 1Y return
- +5.19%
- -37.21%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- 1996
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 4
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Nu Skin Enterprises Inc.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Latest COR
- Executive Vice President Battaglia Silvana was granted 58 shares, increasing direct ownership by 0.25% to 23,624 units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S was granted 50 shares, increasing direct ownership by 0.16% to 30,756 units (SEC Form 4)
- Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
- SEC Form 4 filed by Chief Financial Officer Boratto Eva C
- New insider Boratto Eva C claimed ownership of 3 shares (SEC Form 3)
- Director Tyler Lauren M bought $148,626 worth of shares (550 units at $270.23), increasing direct ownership by 14% to 4,359 units (SEC Form 4)
- Director Durcan Dermot Mark bought $1,096,760 worth of shares (4,000 units at $274.19), increasing direct ownership by 14% to 31,767 units (SEC Form 4)
- SEC Form 11-K filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Announces Samantha Hammock as Chief Human Resources Officer
Latest NUS
- Director Winett James M was granted 26,643 shares and sold $40,481 worth of shares (7,203 units at $5.62) as part of a pre-agreed trading plan, increasing direct ownership by 108% to 37,448 units (SEC Form 4)
- Director Nathanson Laura was granted 26,643 shares, increasing direct ownership by 87% to 57,116 units (SEC Form 4)
- Director Zorko Mark A was granted 26,643 shares, increasing direct ownership by 78% to 60,586 units (SEC Form 4)
- Director Woodbury Edwina D was granted 26,643 shares and sold $41,057 worth of shares (7,203 units at $5.70) as part of a pre-agreed trading plan, increasing direct ownership by 45% to 62,433 units (SEC Form 4)
- Director Battle Emma S. was granted 26,643 shares, increasing direct ownership by 86% to 57,648 units (SEC Form 4)
- Director Thomas Pisano R. was granted 26,643 shares, increasing direct ownership by 30% to 116,827 units (SEC Form 4)
- Director Campbell Daniel W was granted 26,643 shares, increasing direct ownership by 68% to 65,859 units (SEC Form 4)
- SEC Form S-8 filed by Nu Skin Enterprises Inc.
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Nu Skin Enterprises Inc.